Ubiquitination of PPAR-gamma by pVHL inhibits ACLY expression and lipid metabolism, is implicated in tumor progression.

Intracellular lipid accumulation is associated with various diseases, particularly cancer. Mitochondrial dysfunction is considered as a cause of lipid accumulation; however, the related underlying mechanism remains unclear.We found that Von Hippel-Lindau (VHL)-deficiency led to lipid accumulation and mitochondrial dysfunction in renal cell carcinoma cells. Moreover, VHL downregulated ATP-citrate lyase (ACLY), ...
a key enzyme in de novo lipid synthesis, at the transcriptional level, which inhibited intracellular lipid accumulation in human renal carcinoma tissues. We identified PPAR? as the transcription factor regulating ACLY expression by binding to the cis-regulatory site PPRE on its promoter. VHL directly interacted with and promoted ubiquitination of PPAR?, leading to its degradation both in vitro and in vivo, resulting in the downregulation of ACLY. Furthermore, adenovirus-mediated VHL overexpression substantially ameliorated hepatic steatosis induced by a high-fat diet in db/db mice. Importantly, low VHL expression was associated with high ACLY expression and poor prognosis in human liver carcinoma in a dataset in The Cancer Genome Atlas.VHL plays role in cellular lipid metabolism via regulating mitochondria and targeting PPAR?, a transcription factor for ACLY independent of hypoxia-inducible factor 1?. A novel VHL-PPAR?-ACLY axis and its implication in fatty liver disease and cancer were uncovered.
Mesh Terms:
ATP Citrate (pro-S)-Lyase, Animals, Cell Line, Tumor, Disease Progression, Fatty Liver, Humans, Lipid Metabolism, Mice, Neoplasms, PPAR gamma, Proteasome Endopeptidase Complex, Ubiquitination, Von Hippel-Lindau Tumor Suppressor Protein
Metabolism
Date: Dec. 01, 2019
Download Curated Data For This Publication
228909
Switch View:
  • Interactions 6